KK
CSTL icon

KLP Kapitalforvaltning’s Castle Biosciences CSTL Stock Holding History

KLP Kapitalforvaltning’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152K Hold
6,200
– – ﹤0.01% 1923
2025
Q4 		$241K Sell
6,200
-2,700
-30% -$87K ﹤0.01% 1773
2025
Q3 		$203K Buy
8,900
+4,100
+85% +$83.3K ﹤0.01% 1822
2025
Q2 		$98K Hold
4,800
– – ﹤0.01% 2047
2025
Q1 		$96.1K Hold
4,800
– – ﹤0.01% 2041
2024
Q4 		$128K Buy
+4,800
New +$146K ﹤0.01% 2001

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KLP Kapitalforvaltning's CSTL Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Castle Biosciences (CSTL) position steady in Q1 2026 at 6,200 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

KLP Kapitalforvaltning first reported a position in CSTL in Q4 2024 and has held it in 6 quarters since. The position peaked at $241K in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • KLP Kapitalforvaltning held 6,200 shares of Castle Biosciences worth $152K as of Q1 2026.
  • KLP Kapitalforvaltning left its Castle Biosciences share count unchanged in Q1 2026.
  • Castle Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1923 holding.
  • KLP Kapitalforvaltning first reported a position in Castle Biosciences in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Castle Biosciences position peaked at $241K in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.